Cloud DX and Prizm Media to Provide Patients with Direct Access to Remote Patient Monitoring
Patient-First Program Opens Direct Access to thousands of US PatientsCloud DX partners with Prizm Media on a new ‘patient-first' program...
Day: September 16, 2021
NextGen Healthcare Enables ‘Care Anywhere’ for Klamath Tribal Health
NextGen Mobile Empowers Clinics to Deliver Large-Scale COVID-19 Vaccinations ATLANTA--(BUSINESS WIRE)--$NXGN #AmbulatoryHealthcare--NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of...
Neovasc Announces FDA Approval of COSIRA-II Clinical Trial
Company on Schedule to Commence Trial Late This YearVancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - September 16, 2021) -...
ImageCare Centers Unveils PINK Better Mammo Service, Featuring Profound AI®, the World’s First FDA Cleared Artificial Intelligence Solution for 3D Mammography
MORRISTOWN, N.J.--(BUSINESS WIRE)--ImageCare Centers is unveiling its new “PINK Better Mammo” service with the addition of ProFound AI® for Digital...
REMINDER: Jaguar Health to Host Investor Webcast Monday, September 20th at 8:30 AM Eastern Time
Click here to register for webcastJaguar kicks off educational awareness contest in honor of Indigenous Peoples' Day; Click here to...
BriaCell to Present at the Benzinga Healthcare Small Cap Conference September 29-30
BERKELEY, Calif. and VANCOUVER, British Columbia, Sept. 16, 2021 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX-V: BCT)...
Clover Health to Provide In-Home COVID-19 Vaccinations to Medicare Advantage Members
Partnership with MedArrive will help ensure swift vaccine access and administration for Clover’s homebound and most medically complex members, starting...
Y-mAbs Announces Data to be Presented at SIOP 2021
NEW YORK, Sept. 16, 2021 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (“Y-mAbs”, NASDAQ: YMAB), a commercial-stage biopharmaceutical company focused on...
Castellum, Inc. Announces Signing of LOI to Acquire $2 million Government Contractor
Castellum, Inc. Announces Signing of LOI to Acquire $2 million Government Contractor Castellum, Inc. (OTC: ONOV) announces the signing of...
Rakovina Therapeutics Presents Preclinical Data on novel kt-3000 Series Drug Candidates at JCA-AACR Precision Medicine International Conference
VANCOUVER, British Columbia, Sept. 16, 2021 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSXV: RKV) ("the Company"), a biopharmaceutical company committed...
TOMI iHP Disinfection Technology Passes EN 17272 Evaluation
FREDERICK, Md., Sept. 16, 2021 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in...
Pure Extracts Ships Initial Order of Edible Gummies to Alberta
VANCOUVER, British Columbia, Sept. 16, 2021 (GLOBE NEWSWIRE) -- Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (“Pure...
HMNC Brain Health Initiates Pioneering Precision Therapy Program in Mental Health
Pioneering the first large-scale double-blind studies to test the combination of therapies and genetic companion diagnostics in the area of...
ARCA biopharma Announces Enrollment of First International Patient in Phase 2b Clinical Trial Evaluating rNAPc2 as a Potential Treatment for COVID-19
Dr. Bristow Dr. Michael Bristow, President and CEO, ARCA biopharma, Inc. First international patient enrolled in BrazilTrial approximately 75% enrolledrNAPc2...
Aileron Therapeutics Presents New Clinical Data at ESMO Virtual Congress 2021 Supporting ALRN-6924’s Best-in-Class Potential as a Chemoprotective Agent
Final results from completed Phase 1b trial in patients with small cell lung cancer (SCLC) receiving second-line topotecan demonstrated ALRN-6924’s...
Spero Therapeutics to Present Data at IDWeek 2021
CAMBRIDGE, Mass., Sept. 16, 2021 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying,...
Adaptive Biotechnologies to Present New SARS-CoV-2 Data from its Immune Medicine Platform During IDWeek 2021
Research demonstrates the ability of Adaptive’s immune medicine platform to distinguish natural infection from vaccine response and the ability to...
Larimar Therapeutics to Participate in SVB Leerink CybeRx Series: Neuromuscular, Rare Diseases & Genetic Medicines Event
BALA CYNWYD, Pa., Sept. 16, 2021 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR), a clinical-stage biotechnology company focused...
eFFECTOR Therapeutics to Participate in 2021 Cantor Virtual Healthcare Conference
SAN DIEGO, Sept. 16, 2021 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics (NASDAQ: EFTR), a leader in the development of selective translation...
Amolyt Pharma Announces $80 Million Series B Financing led by Sectoral Asset Management and Andera Partners
Funds to be used to continue the clinical development of AZP-3601 for hypoparathyroidism while progressing AZP-3813 through IND-enabling activities in...